BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 1316142)

  • 1. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN)--a preliminary report.
    Cullimore JE; Luesley DM; Rollason TP; Byrne P; Buckley CH; Anderson M; Williams DR; Waddell C; Hudson E; Shafi MI
    Br J Obstet Gynaecol; 1992 Apr; 99(4):314-8. PubMed ID: 1316142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is loop excision adequate primary management of adenocarcinoma in situ of the cervix?
    Houghton SJ; Shafi MI; Rollason TP; Luesley DM
    Br J Obstet Gynaecol; 1997 Mar; 104(3):325-9. PubMed ID: 9091010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of cone margins and post-cone endocervical curettage with residual disease in subsequent hysterectomy.
    Husseinzadeh N; Shbaro I; Wesseler T
    Gynecol Oncol; 1989 May; 33(2):198-200. PubMed ID: 2703181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of residual carcinoma or carcinoma-in-situ at hysterectomy following cervical conization with positive margins.
    Diaz ES; Aoyama C; Baquing MA; Beavis A; Silva E; Holschneider C; Cass I
    Gynecol Oncol; 2014 Jan; 132(1):76-80. PubMed ID: 24262876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of patients with positive margins after cervical conization.
    Lapaquette TK; Dinh TV; Hannigan EV; Doherty MG; Yandell RB; Buchanan VS
    Obstet Gynecol; 1993 Sep; 82(3):440-3. PubMed ID: 8355949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of cervical glandular intraepithelial neoplasia: are hysterectomy specimens sampled appropriately?
    Heatley MK
    J Clin Pathol; 2002 Aug; 55(8):629-30. PubMed ID: 12147662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ.
    Goldstein NS; Mani A
    Am J Clin Pathol; 1998 Jun; 109(6):727-32. PubMed ID: 9620030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting residual lesion in women with cervical adenocarcinoma in situ after cone excisional biopsy.
    Srisomboon J; Kietpeerakool C; Suprasert P; Siriaunkgul S; Khunamornpong S; Prompittayarat W
    Asian Pac J Cancer Prev; 2007; 8(2):225-8. PubMed ID: 17696736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical intraepithelial neoplasia after conization: a study of 522 consecutive cervical cones.
    Abdul-Karim FW; Nuñez C
    Obstet Gynecol; 1985 Jan; 65(1):77-81. PubMed ID: 3966027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after conization for cervical intraepithelial neoplasia grade III: relation with surgical margins, extension to the crypts and mitoses.
    Maluf PJ; Adad SJ; Murta EF
    Tumori; 2004; 90(5):473-7. PubMed ID: 15656332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conization as treatment of carcinoma in situ of the uterine cervix.
    Ahlgren M; Ingemarsson I; Lindberg LG; Nordqvist RB
    Obstet Gynecol; 1975 Aug; 46(2):135-9. PubMed ID: 1153146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of stage Ia1 squamous cervical cancer and the importance of excision margins: a retrospective study of long-term outcome after 25 years of follow-up.
    Papakonstantinou K; Kyrgiou M; Lyons D; Soutter WP; Ghaem-Maghami S
    Am J Obstet Gynecol; 2014 Dec; 211(6):625.e1-6. PubMed ID: 24949540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage Ia1 cervical squamous cell carcinoma: conservative management after laser conization with positive margins.
    Itsukaichi M; Kurata H; Matsushita M; Watanabe M; Sekine M; Aoki Y; Tanaka K
    Gynecol Oncol; 2003 Aug; 90(2):387-9. PubMed ID: 12893205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.